Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 79.17 USD 1.67% Market Closed
Market Cap: 437m USD

Mesa Laboratories Inc
Interest Income Expense

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mesa Laboratories Inc
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Interest Income Expense
-$10.4m
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Interest Income Expense
-$435m
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
-4%
Stryker Corp
NYSE:SYK
Interest Income Expense
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Interest Income Expense
-$143m
CAGR 3-Years
31%
CAGR 5-Years
22%
CAGR 10-Years
N/A
IDEXX Laboratories Inc
NASDAQ:IDXX
Interest Income Expense
-$32.5m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Interest Income Expense
$349.5m
CAGR 3-Years
214%
CAGR 5-Years
15%
CAGR 10-Years
41%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
436.3m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
99.87 USD
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Interest Income Expense?
Interest Income Expense
-10.4m USD

Based on the financial report for Sep 30, 2025, Mesa Laboratories Inc's Interest Income Expense amounts to -10.4m USD.

What is Mesa Laboratories Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-9%

Over the last year, the Interest Income Expense growth was -9%. The average annual Interest Income Expense growth rates for Mesa Laboratories Inc have been -32% over the past three years , -9% over the past five years .

Back to Top